Tate v. Farmland Industries, Inc.

268 F.3d 989, 7 Wage & Hour Cas.2d (BNA) 595, 12 Am. Disabilities Cas. (BNA) 519, 2001 Colo. J. C.A.R. 4916, 2001 U.S. App. LEXIS 21701, 81 Empl. Prac. Dec. (CCH) 40,740, 2001 WL 1205295
CourtCourt of Appeals for the Tenth Circuit
DecidedOctober 10, 2001
Docket99-6329
StatusPublished
Cited by68 cases

This text of 268 F.3d 989 (Tate v. Farmland Industries, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tate v. Farmland Industries, Inc., 268 F.3d 989, 7 Wage & Hour Cas.2d (BNA) 595, 12 Am. Disabilities Cas. (BNA) 519, 2001 Colo. J. C.A.R. 4916, 2001 U.S. App. LEXIS 21701, 81 Empl. Prac. Dec. (CCH) 40,740, 2001 WL 1205295 (10th Cir. 2001).

Opinions

BALDOCK, Circuit Judge.

Defendant Farmland Industries Inc., employed Plaintiff Charles R. Tate in 1987 to operate a commercial motor vehicle (CMV) hauling propane and other refined fuel products.1 In 1995, Plaintiff began taking antiseizure medication to control focal seizures, episodes of jerking on the left side of his body. In 1998, Defendant terminated Plaintiffs employment as a CMV operator due to his health condition. According to Defendant, Plaintiffs use of an-tiseizure medication rendered him physically unqualified to operate a CMV.

Following his termination, Plaintiff filed this action against Defendant alleging violations of (1) the Americans With Disabilities Act (ADA), 42 U.S.C. §§ 12101-12213, and (2) the Family and Medical Leave Act (FMLA), 29 U.S.C. §§ 2601-2654. The [991]*991district court granted summary judgment for Defendant on Plaintiffs ADA claim, and dismissed Plaintiffs FMLA claim for failure to state a cause of action. Plaintiff appeals. We exercise jurisdiction under 28 U.S.C. § 1291. We affirm in part, reverse in part, and remand.

I.

In October 1996, a Department of Transportation (DOT) authorized medical examiner, Dr. Larry G. Stabler, evaluated Plaintiff as required by federal law and issued him a CMV operator’s medical certification. During the examination, Plaintiff disclosed he had been taking the anti-seizure medication Dilantin since the fall of 1995 to control focal seizures related to Lyme Disease. Dr. Stabler examined Plaintiff again in November 1997 for recer-tification. On the medical examination form, Plaintiff again disclosed his use of Dilantin, and, apparently for the first time, also indicated a history of “seizures, fits, convulsions or fainting.” Nevertheless, Dr. Stabler certified Plaintiff as physically qualified to operate a CMV.

Upon reviewing Plaintiffs 1997 certification, Defendant’s Occupational Health Coordinator (OHC) noticed that Plaintiffs examination record reported a history of seizures. The OHC sent a memo to Plaintiffs supervisor requesting additional information. In the memorandum, the OHC wrote that Plaintiff—

indicated a “yes” for seizures, convulsions, and for medications, fists Dilan-tin — an anticonvulsant. Seizures have never been indicated on previous physicals. The physical done a year ago, Dilantin was fisted “as precautionary measure for past history of Lyme disease.” According to the PDR (drug/medication reference), Dilantin is prescribed only for seizure control.

Responding to Defendant’s request for information, Plaintiffs neurologist, Dr. James E. Duncan, sent a letter to Defendant explaining that Plaintiff suffered from focal seizures. Focal seizures are episodes of jerking on the left side of the body without loss of consciousness. Dr. Duncan confirmed that Plaintiff was taking Dilan-tin, but indicated Plaintiff experienced warning symptoms prior to the onset of a seizure. Dr. Duncan also indicated Plaintiff had not suffered a focal seizure in the past two years.

On or about January 2, 1998, Defendant placed Plaintiff on sick leave while determining whether his history of seizures and use of antiseizure medication would permit him to continue working as a CMV operator. Effective January 30, 1998, while Plaintiff remained on sick leave, Defendant officially terminated Plaintiffs employment. According to Defendant, Plaintiff was not physically qualified to operate a CMV because Plaintiffs use of antiseizure medication necessarily prohibited him from meeting the physical requirements for CMV operators.

II.

Subchapter III of the Commercial Motor Vehicle Safety Act, entitled “Safety Regulation,” 49 U.S.C. §§ 31181-31148, authorizes the Secretary of Transportation to prescribe “minimum safety standards” to ensure “the physical condition of operators of commercial motor vehicles is adequate to enable them to operate the vehicles safely.” Id. § 31136(a)(3). To that end, Department of Transportation (DOT) regulations dictate that “[a] person shall not drive a commercial motor vehicle unless he is physically qualified to do so.... ” 49 C.F.R. § 391.41(a). Among other things, a person is physically qualified to drive a CMV if that person “[h]as no established medical history or clinical diag[992]*992nosis of ... any ... condition which is likely to cause loss of consciousness or any loss of ability to control a commercial motor vehicle.” Id. § 391.41(b)(8). DOT’s interpretation of its own regulations strongly suggests that a driver who is taking antiseizure medication for any reason is not qualified to drive a CMV. Department of Transportation’s Federal Highway Administration, Federal Motor Carrier Safety Regulations § 391.41(b)(8), at 411 (Mgmt. ed. 1998) (Medical Advisory Criteria for Evaluation Under 49 C.F.R, Part 391.41) (hereinafter “Medical Advisory Criteria”).

III.

The ADA provides in relevant part that “[n]o covered entity shall discriminate against a qualified individual with a disability because of the disability of such individual in regard to ... discharge of employees, ... and other terms, conditions, and privileges of employment.” 42 U.S.C. § 12112(a). To establish a prima facie case of discrimination under the ADA, a plaintiff must demonstrate “ ‘(1) that [he] is disabled within the meaning of the ADA; (2) that [he] is qualified-with or without reasonable accommodation; and (3) that [he] was discriminated against because of [his] disability.’ ” McKenzie v. Dovala, 242 F.3d 967, 969 (10th Cir.2001) (quoting Aldrich v. Boeing Co., 146 F.3d 1265, 1269 (10th Cir.1998)). The ADA defines the term “disability” as “(A) a physical or mental impairment that substantially limits one or more of the major life activities of such individual; (B) a record of such an impairment; or (C) being regarded as having such an impairment.” 42 U.S.C. § 12102(2).

In granting summary judgment for Defendant on Plaintiffs ADA claim,2 the district court focused on the question of whether Plaintiff was disabled within the meaning of the ADA. The court concluded Plaintiff was not disabled because he failed to establish he was “substantially limited” in the “major life activity” of working. Furthermore, the district court concluded Defendant did not “regard” Plaintiff as disabled, but instead perceived him only as unable to obtain CMV certification under DOT’s Medical Advisory Criteria. We need not decide, however, whether Defendant was disabled as required under the first prong of the ADA’s prima facie case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
268 F.3d 989, 7 Wage & Hour Cas.2d (BNA) 595, 12 Am. Disabilities Cas. (BNA) 519, 2001 Colo. J. C.A.R. 4916, 2001 U.S. App. LEXIS 21701, 81 Empl. Prac. Dec. (CCH) 40,740, 2001 WL 1205295, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tate-v-farmland-industries-inc-ca10-2001.